Formation Bio
7 known investors
Formation Bio develops drugs through partnerships with health systems, academic medical centers, and research sites, focusing on clinical trials in dermatology, rheumatology, and cardiometabolic diseases. The company provides trial management infrastructure, monitoring, technology, and enrollment support to accelerate drug development.
Founders & leadership
BL
Ben LiuCEO & Co-Founder
LZ
Linhao ZhangCo-Founder
Investors · 7
In the news
- This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Fasterforbes.com · 2026
- Mobly Secures $2.5 Million Seed Round to Transform Lead Capture and Qualification in B2B | Presidio Legalpresidio.legal · 2024
- Sanofi-backed Formation Bio raises $372 million in late-stage funding round | Reutersreuters.com · 2024
- Formation Bio secures $372MM Series D funding to grow drug pipeline and continue expanding AI-driven drug development platformprnewswire.com · 2024
- Formation Bio raises $372M to boost drug development with AI | TechCrunchtechcrunch.com · 2024
- Formation Bio - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2024